Related Experiment Video
Updated: Jul 8, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
[Dense cytoplasmic fluorescence on Hep-2 cells: do not overlook anti-PL]
M Krebs1, B Evrard, T Espinouze
1Laboratoire d'immunologie, CHU de Clermont-Ferrand, Hôtel-Dieu, boulevard Léon-Malfreyt, 63058 Clermont-Ferrand cedex 1, France.
This study highlights the importance of thoroughly investigating dense cytoplasmic fluorescence in Hep-2000 cells. It successfully identified anti-PL antibodies, aiding in the diagnosis of antisynthetase syndrome.
Area of Science:
- Immunology
- Autoimmunity
- Cellular fluorescence assays
Context:
- Dense cytoplasmic fluorescence on Hep-2000 cells can indicate various autoimmune conditions.
- Distinguishing between different autoantibodies is crucial for accurate diagnosis and patient management.
Purpose:
- To investigate dense cytoplasmic fluorescence on Hep-2000 cells for the presence of anti-PL antibodies.
- To differentiate anti-PL antibodies from other autoantibodies like anti-ribosomes, anti-JO1, and anti-SSA.
Summary:
- A study of twelve patients with dense cytoplasmic fluorescence on Hep-2000 cells was conducted.
- Testing excluded anti-ribosome and anti-JO1 antibodies, with sera sent for confirmation and anti-PL antibody detection.
- Results showed anti-PL7 (4 patients), anti-PL12 (3 patients), and anti-SSA antibodies (4 patients); one patient had no antibody detected.
Impact:
- Systematic exploration of dense cytoplasmic fluorescence efficiently diagnosed five new cases of antisynthetase syndrome, including three not clinically suspected.
- Improved recognition of anti-PL antibodies, preventing confusion with anti-SSA antibodies.
- Enhanced diagnostic capabilities for autoimmune myopathies.
More Related Videos
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018